Scientific News
Francisco Guarner Aguilar reviewed some of the most significant probiotic-related papers published in recent years, spanning basic research, clinical trials, and population-based studies.
Emma Allen-Vercoe, from University of Guelph (Canada) focuses on the gut microbiome of the Yanomami, whose exceptionally strong cardiometabolic health has attracted growing scientific interest.
Even after long breaks, such as summer vacation, babies continued to share more microbes with former nursery peers than with children from other nurseries.
A longitudinal study aims to explore the trajectories of MCBAs in relation to islet autoimmunity and type 1 diabetes of children.
Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.
Paul Wilmes, University of Luxembourg, explores the concept of infective competence within a One Health framework.
E. coli 541-15 helps the colon recruit key immune cells that can develop into macrophages.
Computer models combining oral bacteria, their metabolic functions, and saliva chemicals could better distinguish obese from healthy individuals compared with clinical measurements alone.
The team developed a machine-learning model using 34 metabolites that could reliably identify depressed individuals.
Piergiorgio Natali (Mediterranean Task force for Cancer Control) discusses the importance of improving functional foods as a strategy to support health, particularly during aging.
A youthful gut microbiota can improve the regenerative function of aged intestinal stem cells.
VOS, an FDA-approved oral microbiota therapy, has been shown to reduce infection risk compared to traditional fecal transplants.
Gut microbes can influence cancer outcomes by regulating nutrient availability and uptake in immune cells.
Lorenza Putignani, Pediatric Hospital Bambino Gesù, Italy, discusses translational research in the microbiome field.
Effective treatment of IBD requires an approach combining tailored donors, microbiota analysis, and diet.
The findings reveal a gut-testis interplay that may explain why low oxygen environments reduce male fertility at high altitudes.
Marika Falcone of San Raffaele Hospital in Milan discusses the growing evidence linking the gut microbiome to extra-intestinal autoimmune diseases.
The oral microbiome is not a dental concern. It is a medical frontier.
Segmented filamentous bacteria, or SFB, protect mice from these deadly infections by reprogramming specific immune cells in the lungs.
The effectiveness of dietary fiber in improving blood sugar in prediabetes depends on an individual’s gut microbiota.
